⌘K

Home/Filings/4/0001171843-14-000719

4//SEC Filing

Capstone Therapeutics Corp. 4

Accession 0001171843-14-000719

$CAPSCIK 0000887151operating

View on SEC.gov Company Profile

Filed

Feb 12, 7:00 PM ET

Accepted

Feb 13, 12:37 PM ET

Size

5.2 KB

Accession

0001171843-14-000719

Insider Transaction Report

Form 4

Period: 2014-02-06

Capstone Therapeutics Corp.CAPS

HOLLIMAN JOHN M III

DirectorExecutive Chairman

Transactions

Award
Stock Option (Right to Buy)
2014-02-06+22,000→ 828,000 total
Exercise: $0.30From: 2014-02-06Exp: 2024-02-06→ Common Stock (22,000 underlying)

Footnotes (1)

[F1]50% to vest 2/6/2014 and 50% to vest monthly by 2/6/2015

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

Capstone Therapeutics Corp.

CIK 0000887151

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000887151

Filing Metadata

Form type: 4
Filed: Feb 12, 7:00 PM ET
Accepted: Feb 13, 12:37 PM ET
Size: 5.2 KB

View on SEC.gov